SCHEMBL17354980

SCHEMBL17354980

CCCCOC1CCC(C2CCC(C3CCC(C)CC3)C(F)C2)C(F)C1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17355015 0.96 — —
SCHEMBL17355006 0.95 GBA1 (0.32) —
SCHEMBL17355011 0.92 — —
SCHEMBL20664257 0.92 — —
SCHEMBL17355018 0.89 — —
SCHEMBL16844688 0.88 PPP5C (0.31) —
SCHEMBL17355038 0.88 — —
SCHEMBL17355025 0.88 CYP1A2 (0.31) —
SCHEMBL17355029 0.87 — —
SCHEMBL17355035 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3428246-B1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2020-04-15 — — EP disclosed
EP-3428246-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2019-01-16 — — EP disclosed
EP-3421569-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2019-01-02 — — EP disclosed
EP-2957618-B1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2018-08-01 — — EP disclosed
US-20180030350-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2018-02-01 — — US disclosed
US-20170044438-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2017-02-16 — — US disclosed
US-20170044438-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2017-02-16 — — US disclosed
EP-2957618-A1 LIQUID CRYSTALLINE MEDIUM Merck Patent GmbH (DE) 2015-12-23 — — EP disclosed
Send feedback